[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 2338 Engrossed in Senate (ES)]
113th CONGRESS
2d Session
S. 2338
_______________________________________________________________________
AN ACT
To reauthorize the United States Anti-Doping Agency, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``United States Anti-Doping Agency
Reauthorization Act''.
SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.
Section 701 of title VII of the Office of National Drug Control
Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
(1) in subsection (a), by striking paragraph (4); and
(2) in subsection (b)--
(A) in paragraph (1), by inserting ``and be
recognized worldwide as the independent national anti-
doping organization for the United States'' after
``Committee'';
(B) in paragraph (2), by striking ``, or
performance-enhancing genetic modifications
accomplished through gene-doping'' and inserting ``or
prohibited performance-enhancing methods adopted by the
Agency'';
(C) in paragraph (3), by striking ``, or
performance-enhancing genetic modifications
accomplished through gene-doping'' and inserting ``or
prohibited performance-enhancing methods adopted by the
Agency'';
(D) in paragraph (4), by striking ``and the
prevention of use of performance-enhancing drugs, or
performance-enhancing genetic modifications
accomplished through gene-doping by United States
amateur athletes; and'' and inserting ``, and the
prevention of use by United States amateur athletes of
performance-enhancing drugs or prohibited performance-
enhancing methods adopted by the Agency.''; and
(E) by striking paragraph (5).
SEC. 3. AUTHORIZATION OF APPROPRIATIONS.
Section 703 of title VII of the Office of National Drug Control
Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read
as follows:
``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.
``There are authorized to be appropriated to the United States
Anti-Doping Agency--
``(1) for fiscal year 2014, $11,300,000;
``(2) for fiscal year 2015, $11,700,000;
``(3) for fiscal year 2016, $12,300,000;
``(4) for fiscal year 2017, $12,900,000;
``(5) for fiscal year 2018, $13,500,000;
``(6) for fiscal year 2019, $14,100,000; and
``(7) for fiscal year 2020, $14,800,000.''.
Passed the Senate December 11, 2014.
Attest:
Secretary.
113th CONGRESS
2d Session
S. 2338
_______________________________________________________________________
AN ACT
To reauthorize the United States Anti-Doping Agency, and for other
purposes.